{"pmid":32305443,"pmcid":"PMC7161526","title":"(United States Cutaneous Lymphoma Consortium) Recommendations for Treatment of Cutaneous Lymphomas During the COVID-19 Pandemic.","text":["(United States Cutaneous Lymphoma Consortium) Recommendations for Treatment of Cutaneous Lymphomas During the COVID-19 Pandemic.","J Am Acad Dermatol","Zic, J A","Ai, W","Akilov, O E","Carter, J B","Duvic, M","Foss, F","Girardi, M","Gru, A A","Kim, E","Musiek, A","Olsen, E A","Schieke, S M","Shinohara, M","Zain, J M","Geskin, L J","32305443"],"journal":"J Am Acad Dermatol","authors":["Zic, J A","Ai, W","Akilov, O E","Carter, J B","Duvic, M","Foss, F","Girardi, M","Gru, A A","Kim, E","Musiek, A","Olsen, E A","Schieke, S M","Shinohara, M","Zain, J M","Geskin, L J"],"date":"2020-04-20T11:00:00Z","year":2020,"_id":"32305443","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.jaad.2020.04.049","keywords":["covid-19","sezary syndrome","cutaneous lymphoma","high-risk","mycosis fungoides"],"source":"PubMed","weight":0,"_version_":1664641855759843330,"score":8.518259,"similar":[{"pmid":32294271,"title":"COVID-19 and Cutaneous manifestations.","text":["COVID-19 and Cutaneous manifestations.","We found that the article on \"Cutaneous manifestations in COVID-19: a first perspective\" is very interesting [1]. Recalcati noted that 20.4 % of the patients have cutaneous problem and mentioned that this is the first report on this clinical aspect of COVID-19.","J Eur Acad Dermatol Venereol","Mungmungpuntipantip, Rujittika","Wiwanitkit, Viroj","32294271"],"abstract":["We found that the article on \"Cutaneous manifestations in COVID-19: a first perspective\" is very interesting [1]. Recalcati noted that 20.4 % of the patients have cutaneous problem and mentioned that this is the first report on this clinical aspect of COVID-19."],"journal":"J Eur Acad Dermatol Venereol","authors":["Mungmungpuntipantip, Rujittika","Wiwanitkit, Viroj"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32294271","week":"202016|Apr 13 - Apr 19","doi":"10.1111/jdv.16483","source":"PubMed","topics":["Diagnosis"],"weight":1,"_version_":1664636192634699776,"score":88.100746},{"pmid":32294264,"title":"Cutaneous manifestations in COVID-19: a new contribution.","text":["Cutaneous manifestations in COVID-19: a new contribution.","We have read with great interest Dr Recalcati's review about skin manifestations in COVID-19 as it is the first report on this subject(1) . In a recent review on clinical characteristics of coronavirus disease 2019 in China, rash was observed in 0,2% of cases(2) . However, from the trained eyes of a dermatologist, this percentage may be higher.","J Eur Acad Dermatol Venereol","Estebanez, Andrea","Perez-Santiago, Leticia","Silva, Esmeralda","Guillen-Climent, Santiago","Garcia-Vazquez, Alejandro","Ramon, M Dolores","32294264"],"abstract":["We have read with great interest Dr Recalcati's review about skin manifestations in COVID-19 as it is the first report on this subject(1) . In a recent review on clinical characteristics of coronavirus disease 2019 in China, rash was observed in 0,2% of cases(2) . However, from the trained eyes of a dermatologist, this percentage may be higher."],"journal":"J Eur Acad Dermatol Venereol","authors":["Estebanez, Andrea","Perez-Santiago, Leticia","Silva, Esmeralda","Guillen-Climent, Santiago","Garcia-Vazquez, Alejandro","Ramon, M Dolores"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32294264","week":"202016|Apr 13 - Apr 19","doi":"10.1111/jdv.16474","keywords":["covid-19","cutaneous","cutaneous manifestations","skin"],"source":"PubMed","topics":["Case Report"],"weight":1,"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664636192544522241,"score":79.40897},{"pmid":32215952,"title":"Cutaneous manifestations in COVID-19: a first perspective.","text":["Cutaneous manifestations in COVID-19: a first perspective.","In December 2019 unexplained pneumonia cases were initially reported in Wuhan, China. The pathogen, a novel coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was isolated from lower respiratory tract samples of infected patients and the resultant disease was termed as COVID-19 (Coronavirus Disease 2019)(1) . By Feb 15, COVID-19 has rapidly spread throughout China and across the world, until a pandemic condition was announced by March 11(2) .","J Eur Acad Dermatol Venereol","Recalcati, S","32215952"],"abstract":["In December 2019 unexplained pneumonia cases were initially reported in Wuhan, China. The pathogen, a novel coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was isolated from lower respiratory tract samples of infected patients and the resultant disease was termed as COVID-19 (Coronavirus Disease 2019)(1) . By Feb 15, COVID-19 has rapidly spread throughout China and across the world, until a pandemic condition was announced by March 11(2) ."],"journal":"J Eur Acad Dermatol Venereol","authors":["Recalcati, S"],"date":"2020-03-28T11:00:00Z","year":2020,"_id":"32215952","week":"202013|Mar 23 - Mar 29","doi":"10.1111/jdv.16387","keywords":["covid-19","cutaneous","cutaneous manifestations","skin"],"source":"PubMed","topics":["Mechanism"],"weight":1,"locations":["Wuhan","China","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664638838225502208,"score":79.40897},{"pmid":32330324,"title":"Acral cutaneous lesions in the Time of COVID-19.","text":["Acral cutaneous lesions in the Time of COVID-19.","Coronavirus disease 2019 (COVID-19) has become a pandemic condition, yet little is known about its dermatologic manifestations. We report here on peculiar (perniosis-like) skin lesions, unreported in the previous years, observed in young outpatients visited in our Dermatologic Unit in the last 4 weeks of COVID-19 pandemic (March-April 2020). Similar cases were referred to us in the same period by Pediatricians and Dermatologists from Italy and European countries.","J Eur Acad Dermatol Venereol","Recalcati, S","Barbagallo, T","Frasin, L A","Prestinari, F","Cogliardi, A","Provero, M C","Dainese, E","Vanzati, A","Fantini, F","32330324"],"abstract":["Coronavirus disease 2019 (COVID-19) has become a pandemic condition, yet little is known about its dermatologic manifestations. We report here on peculiar (perniosis-like) skin lesions, unreported in the previous years, observed in young outpatients visited in our Dermatologic Unit in the last 4 weeks of COVID-19 pandemic (March-April 2020). Similar cases were referred to us in the same period by Pediatricians and Dermatologists from Italy and European countries."],"journal":"J Eur Acad Dermatol Venereol","authors":["Recalcati, S","Barbagallo, T","Frasin, L A","Prestinari, F","Cogliardi, A","Provero, M C","Dainese, E","Vanzati, A","Fantini, F"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32330324","week":"202017|Apr 20 - Apr 26","doi":"10.1111/jdv.16533","keywords":["covid-19","acral lesions","children","cutaneous manifestations","pediatric population","skin"],"source":"PubMed","topics":["Diagnosis"],"weight":1,"locations":["Pediatricians","Dermatologists","Italy"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"_version_":1664996914780700672,"score":79.40897},{"pmid":32330340,"title":"Cutaneous manifestations in COVID-19: the experiences of Barcelona and Rome.","text":["Cutaneous manifestations in COVID-19: the experiences of Barcelona and Rome.","In December 2019, a new virus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing Coronavirus disease 2019 (COVID-19) emerged in Wuhan, Hubei Province, China. SARS-CoV-2 is transmitted through respiratory droplets and object infected with droplets containing the virus. The diagnosis is made employing quantitative reverse transcriptase polymerase chain reaction to identify the viral nucleic acid in respiratory specimens or blood samples.","J Eur Acad Dermatol Venereol","Tammaro, A","Adebanjo, G A R","Parisella, F R","Pezzuto, A","Rello, J","32330340"],"abstract":["In December 2019, a new virus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing Coronavirus disease 2019 (COVID-19) emerged in Wuhan, Hubei Province, China. SARS-CoV-2 is transmitted through respiratory droplets and object infected with droplets containing the virus. The diagnosis is made employing quantitative reverse transcriptase polymerase chain reaction to identify the viral nucleic acid in respiratory specimens or blood samples."],"journal":"J Eur Acad Dermatol Venereol","authors":["Tammaro, A","Adebanjo, G A R","Parisella, F R","Pezzuto, A","Rello, J"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32330340","week":"202017|Apr 20 - Apr 26","doi":"10.1111/jdv.16530","keywords":["covid-19","sars-cov-2","cutaneous","herpetiform lesions","skin manifestations","trunk"],"source":"PubMed","topics":["Diagnosis"],"weight":1,"locations":["Wuhan","Hubei","China","Barcelona","Rome"],"countries":["Italy","Spain","China"],"countries_codes":["ITA|Italy","ESP|Spain","CHN|China"],"_version_":1664996914726174720,"score":75.152824}]}